INTRODUCTION/ OBJECTIVES: The serine/threonine kinase homeodomain-interacting protein kinase 2 (HIPK2) is a co-regulator of an increasing number of transcription factors and cofactors involved in DNA damage response and development. We and others have cloned HIPK2 as an interactor of the p53 oncosuppressor, and have studied the role of this interaction in cell response to stress. Nevertheless, our original cloning of HIPK2 as a p53-binding protein, was aimed at discovering partners of p53 involved in cell differentiation and development, still controversial p53 functions. To this aim, we used p53 as bait in yeast two-hybrid screening of a cDNA library from mouse embryo (day 11 postcoitus) when p53 is highly expressed. METHODS AND RESULTS: In this study, we directly explored whether HIPK2 and p53 cooperate in cell differentiation. By measuring HIPK2 expression and activity in skeletal muscle and haemopoietic differentiation, we observed inverse behaviour of HIPK2 and p53--excluding cooperation activity of these two factors in this event. However, by HIPK2 depletion experiments, we showed that drastic HIPK2 suppression promotes cell-cycle arrest by induction of the cyclin-dependent kinase inhibitor p21(Waf-1/Cip-1). HIPK2 activity is independent of DNA damage and takes place in cell-cycle-arresting conditions, such as terminal differentiation, growth factor deprivation, and G(0) resting. CONCLUSIONS: HIPK2 was found to be involved in cell-cycle regulation dependent on p21(Waf-1/Cip-1) and independent of DNA damage.
INTRODUCTION/ OBJECTIVES: The serine/threonine kinase homeodomain-interacting protein kinase 2 (HIPK2) is a co-regulator of an increasing number of transcription factors and cofactors involved in DNA damage response and development. We and others have cloned HIPK2 as an interactor of the p53 oncosuppressor, and have studied the role of this interaction in cell response to stress. Nevertheless, our original cloning of HIPK2 as a p53-binding protein, was aimed at discovering partners of p53 involved in cell differentiation and development, still controversial p53 functions. To this aim, we used p53 as bait in yeast two-hybrid screening of a cDNA library from mouse embryo (day 11 postcoitus) when p53 is highly expressed. METHODS AND RESULTS: In this study, we directly explored whether HIPK2 and p53 cooperate in cell differentiation. By measuring HIPK2 expression and activity in skeletal muscle and haemopoietic differentiation, we observed inverse behaviour of HIPK2 and p53--excluding cooperation activity of these two factors in this event. However, by HIPK2 depletion experiments, we showed that drastic HIPK2 suppression promotes cell-cycle arrest by induction of the cyclin-dependent kinase inhibitor p21(Waf-1/Cip-1). HIPK2 activity is independent of DNA damage and takes place in cell-cycle-arresting conditions, such as terminal differentiation, growth factor deprivation, and G(0) resting. CONCLUSIONS:HIPK2 was found to be involved in cell-cycle regulation dependent on p21(Waf-1/Cip-1) and independent of DNA damage.
Authors: B Karakas; A Weeraratna; A Abukhdeir; B G Blair; H Konishi; S Arena; K Becker; W Wood; P Argani; A M De Marzo; K E Bachman; B H Park Journal: Oncogene Date: 2006-04-17 Impact factor: 9.867
Authors: Giorgia Bracaglia; Barbara Conca; Anna Bergo; Laura Rusconi; Zhaolan Zhou; Michael E Greenberg; Nicoletta Landsberger; Silvia Soddu; Charlotte Kilstrup-Nielsen Journal: EMBO Rep Date: 2009-10-09 Impact factor: 8.807
Authors: Greg Holmes; Courtney O'Rourke; Susan M Motch Perrine; Na Lu; Harm van Bakel; Joan T Richtsmeier; Ethylin Wang Jabs Journal: Development Date: 2018-10-05 Impact factor: 6.868
Authors: Laureano de la Vega; Juliane Hornung; Elisabeth Kremmer; Maja Milanovic; M Lienhard Schmitz Journal: Nucleic Acids Res Date: 2013-04-24 Impact factor: 16.971
Authors: Fiona M Guerra; Jennifer L Gommerman; Steven A Corfe; Christopher J Paige; Robert Rottapel Journal: PLoS One Date: 2012-04-24 Impact factor: 3.240